⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1631743 | 0.69 | — | — | |
| SCHEMBL6292229 | 0.67 | ALDH1A1 (0.34) | — | |
| SCHEMBL131435 | 0.65 | — | — | |
| SCHEMBL15161767 | 0.64 | — | — | |
| SCHEMBL743876 | 0.62 | — | — | |
| SCHEMBL29660 | 0.60 | — | — | |
| Methane SCHEMBL21683042 | 0.59 | — | — | |
| SCHEMBL4256977 | 0.59 | — | — | |
| SCHEMBL7087320 | 0.59 | — | — | |
| SCHEMBL6955696 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7109338-B2 | For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections. | MARUISHI PHARMACEUTICAL CO., LTD. (JP) | 2006-09-19 | — | — | US | claimed |
| US-20040009977-A1 | 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds | MARUISHI PHARMACEUTICAL CO., LTD. (JP) | 2004-01-15 | — | — | US | claimed |
| EP-1081138-A1 | 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds | Maruishi Pharmaceutical Co., Ltd. (JP) | 2001-03-07 | — | — | EP | claimed |
| US-7319153-B2 | 6,13-Bis(thienyl)pentacene compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-01-15 | — | — | US | disclosed |
| WO-2007016115-A2 | 6,13-BIS(THIENYL)PENTACENE COMPOUNDS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-02-08 | — | — | WO | disclosed |
| US-20070023748-A1 | 6,13-Bis(thienyl)pentacene compounds | 3M INNOVATIVE PROPERTIES COMPANY | 2007-02-01 | — | — | US | disclosed |
| US-7109338-B2 | For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections. | MARUISHI PHARMACEUTICAL CO., LTD. (JP) | 2006-09-19 | — | — | US | disclosed |
| US-20040009977-A1 | 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds | MARUISHI PHARMACEUTICAL CO., LTD. (JP) | 2004-01-15 | — | — | US | disclosed |
| EP-1380575-A1 | 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds | Maruishi Pharmaceutical Co., Ltd. (JP) | 2004-01-14 | — | — | EP | disclosed |
| US-6541470-B1 | Have a potent antiviral activity against picornaviruses and rotaviruses. | MARUISHI PHARMACEUTICAL CO., LTD. (JP) | 2003-04-01 | — | — | US | disclosed |
| EP-1081138-A1 | 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds | Maruishi Pharmaceutical Co., Ltd. (JP) | 2001-03-07 | — | — | EP | disclosed |
| WO-1989009212-A1 | NEW 2,3,4-SUBSTITUTED IMIDAZOLS AND 3,4,5-SUBSTITUTED 1,2,4-TRIAZOLS, PREPARATION AND USE THEREOF | BOEHRINGER INGELHEIM KG (DE) | 1989-10-05 | — | — | WO | disclosed |
| EP-0335381-A1 | 2,3,4-Substituted imidazoles and 3,4,5-substituted 1,2,4-triazoles, their preparation and their use | BOEHRINGER INGELHEIM KG (DE) | 1989-10-04 | — | — | EP | disclosed |